Accuray Inc. Reports Director/Officer Changes & Compensation Updates
Ticker: ARAY · Form: 8-K · Filed: Oct 15, 2024 · CIK: 1138723
| Field | Detail |
|---|---|
| Company | Accuray INC (ARAY) |
| Form Type | 8-K |
| Filed Date | Oct 15, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, executive-compensation, filing-update
TL;DR
Accuray's board/execs shuffled, comp plans updated. Watch for strategic moves.
AI Summary
Accuray Incorporated filed an 8-K on October 15, 2024, reporting changes in its board of directors and executive officers, along with updates to compensatory arrangements. The filing also includes Regulation FD disclosures and financial statements/exhibits, indicating potential shifts in corporate governance and executive compensation.
Why It Matters
Changes in a company's board and executive team can signal strategic shifts or reflect responses to performance, potentially impacting future business direction and shareholder value.
Risk Assessment
Risk Level: medium — Changes in leadership and compensation can indicate underlying business challenges or strategic realignments that may affect future performance.
Key Players & Entities
- ACCURAY INC (company) — Registrant
- October 15, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 608-824-2800 (phone_number) — Registrant's Telephone Number
FAQ
What specific changes were made to the board of directors or executive officers?
The filing indicates changes related to the 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers', but the specific names and details of these changes are not provided in the provided text snippet.
Are there any new compensatory arrangements for certain officers mentioned?
Yes, the filing explicitly lists 'Compensatory Arrangements of Certain Officers' as an item of information, suggesting updates or new arrangements have been made.
What is the significance of the Regulation FD Disclosure item?
Regulation FD (Fair Disclosure) disclosures ensure that material non-public information is broadly disseminated to the public, preventing selective disclosure to analysts or institutional investors.
What types of financial statements and exhibits are included with this filing?
The filing indicates 'Financial Statements and Exhibits' are included, but the specific nature or content of these financial statements and exhibits is not detailed in the provided text.
When was Accuray Incorporated incorporated, and what is its fiscal year end?
Accuray Incorporated was incorporated in Delaware and its fiscal year ends on June 30.
Filing Stats: 608 words · 2 min read · ~2 pages · Grade level 12.2 · Accepted 2024-10-15 09:00:07
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share ARAY The Nasdaq Stock Mar
Filing Documents
- aray-20241015.htm (8-K) — 45KB
- aray-ex99_1.htm (EX-99.1) — 10KB
- img235950492_0.jpg (GRAPHIC) — 18KB
- 0000950170-24-114477.txt ( ) — 197KB
- aray-20241015.xsd (EX-101.SCH) — 29KB
- aray-20241015_htm.xml (XML) — 4KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On October 15, 2024, the Company issued a press release related to the matter described in Item 5.02 of this Current Report on Form 8-K. A copy of this press release is furnished herewith as Exhibit 99.1. The information contained in this Item 7.01 disclosure, including Exhibit 99.1, is furnished pursuant to Item 7.01 and shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be incorporated by reference into a filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release dated October 15, 2024, titled "Accuray President and Chief Executive Officer Suzanne Winter Returns from Medical Leave of Absence" 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ACCURAY INCORPORATED Dated: October 15, 2024 By: /s/ Jesse Chew Jesse Chew Senior Vice President, Chief Legal Officer & Corporate Secretary 3